1. Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development.
- Author
-
Muralikrishnan A, Sekar M, Kumarasamy V, Gan SH, Ravi S, Subramaniyan V, Wong LS, Wu YS, Khattulanuar FS, and Mat Rani NNI
- Subjects
- Humans, Animals, Drug Development, Butyrates pharmacology, Butyrates chemistry, Butyrates therapeutic use, Benzopyrans pharmacology, Benzopyrans chemistry, Benzopyrans isolation & purification, Drug Discovery, Angelica chemistry
- Abstract
Decursin is a pyranocoumarin compounds which are rare secondary metabolic plant products, isolated from the roots of Angelica gigas (A. gigas) . The native Korean species Angelica gigas Nakai (AGN) is widely used as a remedy for a variety of medical conditions including hematopoiesis, improving women's circulation, as sedatives, analgesics and tonic. It is unique because of the presence of substantial amounts of pyranocoumarins including decursin, decursinol, and decursinol angelate. In this review, we provide a comprehensive insight into the distribution, morphology, and chemical composition of A. gigas . A detailed discussion regarding the biological applications of decursin based on the literature retrieved from PubMed, ScienceDirect, Scopus, and Google Scholar from 2000 to the present has been discussed. Both in vitro and in vivo studies have demonstrated that decursin has potential neuroprotective, anti-inflammatory, anti-melanogenic, anti-angiogenic, antioxidant, and anti-visceral properties. Mechanistic findings establish its significance in regulating important signalling pathways, triggering apoptosis, and preventing metastasis in different cancer types. The review additionally addressed the isolation methods, biosynthesis, physiochemical characteristics, toxicity and pharmacokinetic profile of decursin. The present state of clinical studies including A. gigas is investigated, emphasizing its advancements and possibilities in the field of translational medicine., Competing Interests: The authors report no conflicts of interest in this work., (© 2024 Muralikrishnan et al.)
- Published
- 2024
- Full Text
- View/download PDF